Ciranova Announce Investment by Intel Capital

Ciranova Inc., a technology leader in analog IC physical design automation, announced today that Intel Capital, Intel Corporation’s global investment organization, has made an investment in the company.

The funding will be used to expand the company’s sales and customer support operations and for specific extensions to the company’s technology.

Ciranova’s automated-design software helps engineers integrate complex RF, analog and mixed-signal content into nanometer-scale silicon much more densely and quickly than previously possible. Ciranova® technology is used by semiconductor companies integrating Wi-Fi, Bluetooth, SERDES and other functions into high-end system-on-chip (SoC) designs at 65nm and below.

“Silicon for consumer devices, especially mobile internet and broadband, now demands very aggressive mixed-signal integration in nanometer CMOS,” said Eric Filseth, Ciranova CEO. “But putting many radios or other analog functions into a single chip, together with digital, is extremely challenging using traditional analog methods. Our approach is much better suited to the complex process rules and large-scale designs associated with SoCs, and we’re delighted that Intel Capital has chosen to invest in our company.”

“The productivity gap in analog/mixed-signal design automation has been growing at a much faster rate than the productivity gap in digital design. Increased automation in analog design flows is needed to ensure acceptable design times for analog/mixed–signal circuits,” said Shishpal Rawat, director of business enabling programs with the Design Technology Solutions Group, Intel. “Ciranova’s approach could improve turnaround time in analog layout automation, a key component of the overall analog/mixed-signal design flow.”

Source: http://www.ciranova.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.